UBS Group’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

UBS Group’s Portfolio HCAR Stock Details HCAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,606	Closed	-$26K	–	11612
2022 Q3	$26K	Sell	2,606 -10,430	-80%	-$103K	﹤0.01%	7084
2022 Q2	$128K	Buy	+13,036	New	+$128K	﹤0.01%	5239
2022 Q1	–	Sell	-8	Closed	–	–	11364
2021 Q4	$0	Sell	8 -723	-99%	-$7.06K	﹤0.01%	11106
2021 Q3	$7K	Sell	731 -2,091	-74%	-$20.2K	﹤0.01%	8367
2021 Q2	$27K	Buy	2,822 +1,079	+62%	+$10.5K	﹤0.01%	7058
2021 Q1	$17K	Buy	+1,743	New	+$17.5K	﹤0.01%	7539

UBS Group's HCAR Position: Q4 2022 in Review

UBS Group sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 2,606 shares — an estimated $26K sold.

UBS Group first reported a position in HCAR in Q1 2021 and held it in 6 quarters. The position peaked at $128K in Q2 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

UBS Group reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 2,606 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $26K.
UBS Group first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q1 2021 and held it in 6 quarters.
UBS Group's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $128K in Q2 2022.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.